Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2181302
Max Phase: Preclinical
Molecular Formula: C48H73N13O9
Molecular Weight: 976.19
Molecule Type: Protein
Associated Items:
ID: ALA2181302
Max Phase: Preclinical
Molecular Formula: C48H73N13O9
Molecular Weight: 976.19
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccccc1)C(N)=O
Standard InChI: InChI=1S/C48H73N13O9/c1-27(2)22-35(44(67)56-33(18-12-20-54-48(52)53)43(66)57-34(40(51)63)25-31-16-10-7-11-17-31)59-46(69)38-19-13-21-61(38)47(70)37(23-28(3)4)60-45(68)36(26-39(50)62)58-41(64)29(5)55-42(65)32(49)24-30-14-8-6-9-15-30/h6-11,14-17,27-29,32-38H,12-13,18-26,49H2,1-5H3,(H2,50,62)(H2,51,63)(H,55,65)(H,56,67)(H,57,66)(H,58,64)(H,59,69)(H,60,68)(H4,52,53,54)/t29-,32-,33-,34-,35-,36-,37-,38-/m0/s1
Standard InChI Key: LHVNYTHQATYMMA-YBHWYGJSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 976.19 | Molecular Weight (Monoisotopic): 975.5654 | AlogP: -1.57 | #Rotatable Bonds: 28 |
Polar Surface Area: 369.01 | Molecular Species: BASE | HBA: 11 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 22 | HBD (Lipinski): 16 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.70 | CX Basic pKa: 11.50 | CX LogP: -2.15 | CX LogD: -4.30 |
Aromatic Rings: 2 | Heavy Atoms: 70 | QED Weighted: 0.03 | Np Likeness Score: -0.02 |
1. Nichols R, Bass C, Demers L, Larsen B, Li E, Blewett N, Converso-Baran K, Russell MW, Westfall MV.. (2012) Structure-activity studies of RFamide-related peptide-1 identify a functional receptor antagonist and novel cardiac myocyte signaling pathway involved in contractile performance., 55 (17): [PMID:22909119] [10.1021/jm300760m] |
Source(1):